|
2024
|
Invention
|
Method of verifying a program code of a synthesis computer program.
A method of verifying a prog... |
|
|
Invention
|
Pyrazole derivatives as sting agonists.
The present invention provides novel compounds having th... |
|
|
Invention
|
Synthesis of quinazoline compounds.
Provided herein are methods of synthesizing quinazoline comp... |
|
|
Invention
|
Spiro-oxazolones.
The present invention provides spiro-oxazolones, which act as V1a receptor mod... |
|
|
Invention
|
Pet tracers for visualizing gabaa gamma1 receptors.
The present invention provides radiolabeled ... |
|
|
Invention
|
Anti-hla-g antibodies and methods of use thereof.
The present invention relates to anti-HLA-G an... |
|
|
Invention
|
Oligonucleotides for modulating tau expression.
The present invention relates to antisense oligo... |
|
|
Invention
|
Folr1 protease-activatable t cell bispecific antibodies.
The present invention generally relates... |
|
|
Invention
|
Chimeric receptors.
The present invention generally relates to chimeric receptors comprising an ... |
|
|
Invention
|
Antibody formulation. This invention relates to a pharmaceutical formulation of an alpha synuclei... |
|
|
Invention
|
Machine learning models for cell line selection.
Methods for facilitating selection of cell line... |
|
|
Invention
|
Machine learning models for cell line selection. Methods for facilitating selection of cell lines... |
|
|
Invention
|
Gene biomarkers for mammalian cell pool productivity prediction and screening. Methods for select... |
|
|
Invention
|
New prop-2-ynamide derivatives. 133 are as defined in the description and in the claims. The comp... |
|
|
Invention
|
Novel methods for preparing semi-solid compositions and uses thereof. The present application dis... |
|
|
Invention
|
Inhibitors of the nlrp3 inflammasome. xyy are as described herein, composition including the comp... |
|
|
Invention
|
Container integrity testing system and method. A CCI testing system (1) to test closure integrity... |
|
|
Invention
|
Container intergity testing method and system. A CCI testing method to test physical container cl... |
|
|
Invention
|
Treatment of non small cell lung cancer with alectinib. The present invention relates to a method... |
|
|
Invention
|
Processes for the preparation of phenyltetrahydrofuran compounds.
Provided are phenyltetrahydrof... |
|
|
Invention
|
Method for the generation of single stranded dna. The present invention relates to a method for t... |
|
|
Invention
|
Pyrazole derivatives as sarm1 inhibitors useful for the treatment of neurodegenerative disorders.... |
|
|
Invention
|
Antisense oligonucleotide for targeting progranulin.
The present invention relates to oligonucle... |
|
|
Invention
|
Protease activatable fc domain binding molecules. The present invention generally relates to nove... |
|
|
Invention
|
Process for the preparation of preparing 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamo... |
|
|
Invention
|
Methods of treatment. Herein is reported the use of RG6035 as a medicament in the treatment of mu... |
|
|
Invention
|
Pharmaceutical formulation comprising a coated tablet. The invention relates to pharmaceutical fo... |
|
|
Invention
|
Liver cirrhosis detection in digital images.
The present invention relates to systems and method... |
|
|
Invention
|
Anti-a-beta protein antibodies, methods and uses thereof.
Herein is reported an antibody that bi... |
|
|
Invention
|
Process for the preparation of 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyr... |
|
|
Invention
|
Process for preparing btk inhibitors.
Methods for preparing the Bruton's Tyrosine Kinase (“BTK”)... |
|
|
Invention
|
Anti-a-beta protein antibodies, methods and uses thereof. Herein is reported an antibody that bin... |
|
|
Invention
|
Mono and multispecific anti-trem2 antibodies, methods and uses thereof. Herein is reported an ant... |
|
|
Invention
|
Her2-targeting antigen binding molecules comprising 4-1bbl.
The invention relates to Her2 target... |
|
|
Invention
|
Agonistic cd28 antigen binding molecules targeting her2.
The present invention relates to Her2-t... |
|
|
Invention
|
Antibodies binding to cd3.
The present invention generally relates to antibodies that bind to CD... |
|
|
Invention
|
Process for synthesis of quinazoline compounds.
Provided herein are methods to synthesize compou... |
|
|
Invention
|
Multispecific antibodies and use thereof.
The present invention relates to multispecific antibod... |
|
|
Invention
|
Mutant transaminase with increased asymmetric reductive amination activity as well as methods and... |
|
|
Invention
|
Immunoconjugates.
The present invention generally relates to immunoconjugates, particularly immu... |
|
|
Invention
|
Antigen binding molecules comprising a tnf family ligand trimer.
The invention relates to novel ... |
|
|
Invention
|
Antiviral compounds.
The invention provides viral protease inhibitors having the general formula... |
|
|
Invention
|
Synthesis of a bis-mesylate salt of 4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquin... |
|
|
Invention
|
Quantification of low amounts of antibody side-products.
The current invention is directed to a ... |
|
|
Invention
|
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma.
Provided he... |
|
|
Invention
|
Combination therapy of anti-tyrp1/anti-cd3 bispecific antibodies and tyrp1-specific antibodies.
... |
|
|
G/S
|
Antibiotic Preparation |
|
2023
|
Invention
|
Heterocyclic compounds.
The invention provides new heterocyclic compounds having the general for... |
|
2022
|
Invention
|
Bicyclic heterocyclic compounds useful as monoacylglycerol lipase inhibitors.
The invention prov... |
|
|
Invention
|
Novel heteroaryl compounds.
The invention provides new heteroaromatic compounds having the gener... |
|
|
G/S
|
Online-information services, namely, providing on-line information about accessing computer netwo... |
|
2019
|
G/S
|
Medical and scientific research in the field of diabetes; Consultation pertaining to pharmacology... |
|
2017
|
G/S
|
laboratory instruments, namely, clinical chemistry analyzers and immunochemistry analyzers for th... |
|
|
G/S
|
a full line of in vitro diagnostic agent, namely, reagents, control solutions for calibrating and... |
|
|
G/S
|
medical diagnostic test strips for determining the level of glucose in blood for medical and clin... |
|
|
G/S
|
blood glucose monitors for medical purposes, lancet devices, lancets; insulin delivery devices an... |
|
2008
|
G/S
|
full line of pharmaceutical preparations |
|
|
G/S
|
pharmaceutical antiviral preparation |
|
2000
|
G/S
|
[ Chemical products, namely, diagnostic preparations for scientific or medical research use; cont... |
|
1999
|
G/S
|
providing information about a pharmaceutical company and its products and services via a web site... |
|
1997
|
G/S
|
pharmaceutical preparation, namely, an anticancer drug |
|
1994
|
G/S
|
pharmaceutical preparation; namely, an antiviral |
|
1993
|
G/S
|
pharmaceutical preparation, namely an immunosuppressive agent |
|
1985
|
G/S
|
COMPUTERS AND ELECTRONIC LABORATORY TESTING APPARATUS USED FOR ANALYSIS OF BIOLOGICAL FLUIDS, PHA... |
|
1984
|
G/S
|
Clinical Laboratory Services |
|
1977
|
G/S
|
[ PROVIDING COMPUTER SCORED PSYCHIATRIC AND PSYCHOLOGICAL TESTING SERVICES; ] PROVIDING PHARMACEU... |
|
|
G/S
|
MEDICAL BOOKLETS AND PAMPHLETS |
|
|
G/S
|
PHARMACEUTICAL PREPARATIONS FOR HUMAN [AND VETERINARY] USE |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS[; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE C... |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS [ ; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE... |
|
1949
|
G/S
|
[ AGENTS USED IN ALLERGY, ANALGESICS, ANALEPTICS, ] ANTI-INFECTIVES [, ANTISPASMODICS ANESTHETIC... |
|
1897
|
G/S
|
CHEMICAL PRODUCTS FOR USE IN MEDICINE AND PHARMACY [ , DISINFECTANTS, AND PERFUMES ] |
